Triphase Accelerator Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 4

Triphase Accelerator General Information

Description

Developer of novel therapeutics intended to accelerate the development of promising cancer therapies. The company's novel therapeutics focuses on accelerating oncology products from the pre-investigational new drug in less time with less capital than traditional pharma and biotech approaches, enabling cancer patients to get more effective, affordable treatments, faster than traditional drug development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Drug Discovery
Primary Office
  • 661 University Avenue
  • Suite 415
  • Toronto, Ontario M5G 1M1
  • Canada
+1 (647) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Triphase Accelerator Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 18-Apr-2016 Completed Generating Revenue
2. Corporate 24-Oct-2014 Completed Generating Revenue
1. Early Stage VC 09-Jan-2014 Completed Generating Revenue
To view Triphase Accelerator’s complete valuation and funding history, request access »

Triphase Accelerator Executive Team (6)

Name Title Board Seat Contact Info
Grant Gibson Chief Financial Officer & Chief Administrative Officer
Ilse Treurnicht Ph.D Executive Chairman
Raphael Hofstein Ph.D Co-Founder & Board Member
You’re viewing 3 of 6 executive team members. Get the full list »

Triphase Accelerator Board Members (8)

Name Representing Role Since
David O'Neill Ph.D Triphase Accelerator Board Member 000 0000
Ilse Treurnicht Ph.D Triphase Accelerator Executive Chairman 000 0000
Kevin Leshuk Triphase Accelerator Board Member 000 0000
Parimal Nathwani Triphase Accelerator Board Member 000 0000
Raphael Hofstein Ph.D Self Co-Founder & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Triphase Accelerator Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Triphase Accelerator Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
FACIT Venture Capital Minority 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Triphase Accelerator’s complete investors history, request access »

Triphase Accelerator Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000000000000000000 Drug Delivery
To view Triphase Accelerator’s complete acquisitions history, request access »